Cellectis SA (CLLS)
3.21
-0.20
(-5.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
0.00 (0.00%)
After-Hours: 19:57
Cellectis Debt to Equity Ratio : 2.539 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.539 |
| March 31, 2026 | 1.812 |
| December 31, 2025 | 1.580 |
| September 30, 2025 | 1.186 |
| June 30, 2025 | 1.172 |
| March 31, 2025 | 0.9365 |
| December 31, 2024 | 0.8368 |
| September 30, 2024 | 0.8663 |
| June 30, 2024 | 0.7414 |
| March 31, 2024 | 1.149 |
| December 31, 2023 | 1.096 |
| September 30, 2023 | 1.318 |
| June 30, 2023 | 1.034 |
| March 31, 2023 | 0.7146 |
| December 31, 2022 | 0.6423 |
| September 30, 2022 | 0.7073 |
| June 30, 2022 | 0.6016 |
| March 31, 2022 | 0.5711 |
| December 31, 2021 | 0.4558 |
| September 30, 2021 | 0.4395 |
| June 30, 2021 | 0.3876 |
| March 31, 2021 | 0.4138 |
| December 31, 2020 | 0.3871 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.3553 |
| June 30, 2020 | 0.2447 |
| March 31, 2020 | 0.1508 |
| December 31, 2019 | 0.1511 |
| September 30, 2019 | 0.1393 |
| June 30, 2019 | 0.1314 |
| March 31, 2019 | 0.0911 |
| December 31, 2018 | 0.0033 |
| September 30, 2018 | 0.0007 |
| June 30, 2018 | 0.0022 |
| March 31, 2018 | 0.0014 |
| December 31, 2017 | 0.0001 |
| September 30, 2017 | 0.0002 |
| June 30, 2017 | 0.0003 |
| March 31, 2017 | 0.0002 |
| December 31, 2016 | 0.0064 |
| September 30, 2016 | 0.0077 |
| June 30, 2016 | 0.0087 |
| March 31, 2016 | 0.008 |
| December 31, 2015 | 0.0076 |
| September 30, 2015 | 0.0128 |
| June 30, 2015 | 0.0129 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | 0.0784 |
| Akari Therapeutics Plc | 0.0373 |
| EDAP TMS SA | -12.92 |
| Autolus Therapeutics Plc | 4.915 |
| Evaxion AS | 0.7455 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 267.36M |
| Total Liabilities (Quarterly) | 226.30M |
| Shareholders Equity (Quarterly) | 41.07M |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 0.30% |